APA Citatie

Piccinni, M., Lombardelli, L., Logiodice, F., Kullolli, O., Maggi, E., & Barkley, M. S. (2019). Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease. Front Immunol.

Chicago Style citaat

Piccinni, Marie-Pierre, Letizia Lombardelli, Federica Logiodice, Ornela Kullolli, Enrico Maggi, en Marylynn S. Barkley. "Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses Via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease." Front Immunol 2019.

MLA citatie

Piccinni, Marie-Pierre, et al. "Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses Via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease." Front Immunol 2019.